Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

Protara Therapeutics, Inc. TARA

Full chart Compare
Set alert

Price alert · TARA

All alert types
2.43 USD -0.08 (-3.19%)

At closeNov 10, 2026, 4:01 PM EST

2.43 0.00 0.00%

After hours · Nov 10, 4:01 PM ET

2.33 Day range 2.51
2.09 52-week range 7.82
YTD
-54.41%
1 year
-46.36%

Financial health

Altman Z-Score

1.44 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

B-2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -4.0×
FY 2016: -1.1×FY 2017: -1.1×FY 2018: -9.1×FY 2019: -4.5×FY 2020: -5.2×FY 2021: -1.6×FY 2022: -0.5×FY 2023: -0.5×FY 2024: -2.4×FY 2025: -4.0×
FY 2016 5y median -1.6× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.2×
FY 2016: 0.8×FY 2017: 0.9×FY 2018: 11.4×FY 2019: 10.4×FY 2020: 0.9×FY 2021: 0.5×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.7×FY 2025: 1.2×
FY 2016 5y median 0.5× FY 2025
P/FCF -4.0×
FY 2016: -1.3×FY 2017: -1.5×FY 2018: -10.0×FY 2019: -4.3×FY 2020: -7.2×FY 2021: -2.2×FY 2022: -1.1×FY 2023: -0.6×FY 2024: -3.0×FY 2025: -4.0×
FY 2016 5y median -2.2× FY 2025
EV/EBITDA -3.2×
FY 2016: 0.2×FY 2017: -0.4×FY 2018: -10.3×FY 2019: -7.7×FY 2020: -0.2×FY 2021: -1.0×FY 2022: -0.2×FY 2023: 0.3×FY 2024: 1.1×FY 2025: -3.2×
FY 2016 5y median -0.2× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -24.7%
FY 2016: -76.1%FY 2017: -68.2%FY 2018: -10.0%FY 2019: -23.5%FY 2020: -13.9%FY 2021: -46.3%FY 2022: -88.1%FY 2023: -176.5%FY 2024: -33.0%FY 2025: -24.7%
FY 2016 5y median -46.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -29.2%
FY 2016: -74.2%FY 2017: -86.3%FY 2018: -124.4%FY 2019: -234.5%FY 2020: -17.1%FY 2021: -29.2%FY 2022: -64.6%FY 2023: -59.2%FY 2024: -26.7%FY 2025: -29.2%
FY 2016 5y median -29.2% FY 2025
ROIC -32.3%
FY 2016: -74.7%FY 2017: -87.4%FY 2018: -127.6%FY 2019: -214.9%FY 2020: -17.2%FY 2021: -28.1%FY 2022: -61.8%FY 2023: -59.1%FY 2024: -28.6%FY 2025: -32.3%
FY 2016 5y median -32.3% FY 2025
ROA -27.4%
FY 2016: -65.5%FY 2017: -68.1%FY 2018: -108.1%FY 2019: -214.9%FY 2020: -16.7%FY 2021: -27.4%FY 2022: -58.2%FY 2023: -51.2%FY 2024: -24.6%FY 2025: -27.4%
FY 2016 5y median -27.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -31.3%
FY 2016: -37.5%FY 2017: -5.8%FY 2018: 14.1%FY 2019: 41.5%FY 2020: -125.8%FY 2021: -37.9%FY 2022: -41.2%FY 2023: 35.0%FY 2024: -12.7%FY 2025: -31.3%
FY 2016 FY 2025
EPS (diluted) 38.2%
FY 2016: -32.7%FY 2017: -0.7%FY 2018: 85.7%FY 2019: 63.4%FY 2020: -29.5%FY 2021: 10.6%FY 2022: -39.5%FY 2023: 39.1%FY 2024: 39.2%FY 2025: 38.2%
FY 2016 FY 2025
Free Cash Flow -57.4%
FY 2016: -34.9%FY 2017: 6.6%FY 2018: -4.3%FY 2019: 32.9%FY 2020: -55.1%FY 2021: -44.5%FY 2022: 24.3%FY 2023: -41.5%FY 2024: 4.6%FY 2025: -57.4%
FY 2016 FY 2025

Financial Health

Current Ratio 14.6×
FY 2016: 8.4×FY 2017: 4.7×FY 2018: 7.5×FY 2019: 12.0×FY 2020: 58.1×FY 2021: 21.7×FY 2022: 15.0×FY 2023: 11.2×FY 2024: 15.7×FY 2025: 14.6×
FY 2016 5y median 15.0× FY 2025
Quick Ratio 14.6×
FY 2016: 8.4×FY 2017: 4.7×FY 2018: 7.5×FY 2019: 12.0×FY 2020: 58.1×FY 2021: 21.7×FY 2022: 14.8×FY 2023: 11.2×FY 2024: 15.7×FY 2025: 14.6×
FY 2016 5y median 14.8× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.8×
FY 2016: 1.3×FY 2017: 0.7×FY 2018: 0.9×FY 2019: 0.8×FY 2020: 5.0×FY 2021: 0.6×FY 2022: 0.3×FY 2023: 0.9×FY 2024: 3.6×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2016: -149×FY 2017: -117×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -1013×FY 2021: -27.3×FY 2022: -59.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31